COVID-19 Update | September 4, 2020

COVID-19 News

COVID-19 Update | September 4, 2020

September 4, 2020

The California Biotechnology Foundation is committed to keeping you up to date about COVID-19 testing, treatment and prevention advancements. The following resources track what progress has been made as of September 4, 2020. Notable advancements include:

  • Pfizer announced its late-stage COVID-19 vaccine trial may have results as early as October.
  • AstraZeneca started phase 3 trials of its COVID-19 vaccine in the United States.
  • Gilead Sciences announced remdesivir received expanded Emergency Use Authorization from the FDA, enabling the drug’s use to treat all hospitalized patients with COVID-19.

Recent News:

Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.

Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new

If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or [email protected].